A critical discovery in cancer study is occurring with the use of VHH fragments to re-engage dysfunctional p53. This essential cancer inhibitor protein is frequently lost in several forms of cancer, leading https://socialwebconsult.com/story7463330/mini-antibodies-revive-the-p53-protein-the-new-approach-for-cancer-therapy